Dr. Matthew S. Smith

Frank Lieberman is a Neurologist in Pittsburgh, Pennsylvania. Dr. Lieberman is rated as an Elite provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

Riddhi Patira, MD, is a neurologist certified in neuropsychiatry and behavioral neurology by the American Board of Psychiatry and Neurology. She is investigator of the Alzheimer’s Disease Research Center and leader of the Frontotemporal Dementia Consortium. She is also an assistant professor of Neurology at the University of Pittsburgh School of Medicine. She received her medical degree from Pandit Ravishankar Shukla University and completed her residency at Temple University, followed by her fellowship at the University of Pennsylvania. Dr. Patira’s clinical and research interests focus on the various cognitive disorders, especially neurodegenerative diseases such as Alzheimer’s disease, frontotemporal dementia, and other types of dementia. She has published numerous articles in peer-reviewed journals and is a member of the American Academy of Neurology. View the full list of Dr. Patira’s publications on PubMed. https://pubmed.ncbi.nlm.nih.gov/?term=Patira%2C+R. Dr. Patira is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Her top areas of expertise are Apraxia, Dysembryoplastic Neuroepithelial Tumors (DNET), Memory Loss, and Primary Progressive Aphasia.

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer. Dr. Drappatz is rated as an Elite provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.